G2TT
来源类型Report
规范类型报告
DOIhttps://doi.org/10.7249/RR3247
来源IDRR-3247-EFPIA
Reuse of health data by the European pharmaceutical industry: Current practice and implications for the future
Lucy Hocking; Sarah Parks; Marlene Altenhofer; Salil Gunashekar
发表日期2019-11-12
出版年2019
页码103
语种英语
结论 Reuse of health data by the European pharmaceutical industry: Current practice and implications for the future | RAND
摘要

The health data landscape is rapidly evolving, with a growing recognition within the pharmaceutical industry of the potential benefits of reusing health data for secondary analysis. A new study by RAND Europe, commissioned by the European Federation of Pharmaceutical Industries and Associations, explored current practices in relation to this.

,

The study found that health data is reused across the research and development pathway for a variety of reasons, with the most frequently reused data being electronic health records, health registry data and clinical trial data. Researchers also identified several barriers and enablers to reusing health data, highlighting a number of priority topics which could help to create a more sustainable ecosystem in which health data is reused effectively. These included the need for continued research and development on analytic tools and promoting the adoption of standards and interoperability across datasets, to building public confidence and trust in the pharmaceutical industry to reuse health data and greater collaboration between industry and other key stakeholders.

目录
  • Chapter One

    Introduction

  • Chapter Two

    Case vignettes illustrating how the pharmaceutical industry in Europe is reusing health data

  • Chapter Three

    How is the pharmaceutical industry reusing health data?

  • Chapter Four

    What are the enablers and barriers to reusing health data?

  • Chapter Five

    Reflections on the future of the reuse of health data

  • Annex A

    Methodological approach

主题Big Data ; Electronic Medical Records ; Health Information Privacy ; Health Information Technology Interoperability ; Pharmaceutical Drugs
URLhttps://www.rand.org/pubs/research_reports/RR3247.html
来源智库RAND Corporation (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/523933
推荐引用方式
GB/T 7714
Lucy Hocking,Sarah Parks,Marlene Altenhofer,et al. Reuse of health data by the European pharmaceutical industry: Current practice and implications for the future. 2019.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RR3247.pdf(1309KB)智库出版物 限制开放CC BY-NC-SA浏览
1600371833885.jpg(7KB)智库出版物 限制开放CC BY-NC-SA缩略图
浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Lucy Hocking]的文章
[Sarah Parks]的文章
[Marlene Altenhofer]的文章
百度学术
百度学术中相似的文章
[Lucy Hocking]的文章
[Sarah Parks]的文章
[Marlene Altenhofer]的文章
必应学术
必应学术中相似的文章
[Lucy Hocking]的文章
[Sarah Parks]的文章
[Marlene Altenhofer]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RR3247.pdf
格式: Adobe PDF
文件名: 1600371833885.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。